US · Healthcare

CARsgen Therapeutics Holdings Limited (CRTHF)

Biotechnology

CARsgen Therapeutics Holdings Limited (CRTHF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CRTHF

P/E ratio

18.00

CARsgen Therapeutics Holdings Limited (CRTHF) — FAQ

What is CRTHF's P/E ratio?

The price-to-earnings (P/E) ratio for CARsgen Therapeutics Holdings Limited (CRTHF) is 18.00 (data as of 2026-03-24).

Does CARsgen Therapeutics Holdings Limited pay a dividend?

Dividend yield is not available in the current snapshot for CARsgen Therapeutics Holdings Limited (CRTHF). Check the MyAverix Finance app for the latest dividend data.

What sector is CARsgen Therapeutics Holdings Limited in?

CARsgen Therapeutics Holdings Limited (CRTHF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CRTHF listed on?

CRTHF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)